Chronic Myelogenous Leukemia research hub

Asciminib Roll-over Study

This study is for people who have already been taking a medicine called asciminib (or similar drugs) in a Novartis study for a type of blood cancer called CML. It allows them to keep taking the medicine if their doctor thinks it's still helping them.